Dear Colleagues,
We invite you to kindly take part in this 10-minute survey aimed to assess the awareness, knowledge, and practices of physicians regarding drug hypersensitivity reactions (DHRs) in patients with primary immunodeficiencies (PID).
The occurence of DHR in PIDs remains a largely unaddressed area. However, PID patients often receive prolonged or repeated courses of antimicrobials for prophylaxis or treatment, as well as other medications that could pose a risk of hypersensitivity reactions.
Your responses will help us assess physicians' awareness, knowledge, and clinical practices in this area, identifying gaps that can guide future educational initiatives and clinical guidelines.
All data will be handled anonymously and confidentially.
No personally identifiable information will be collected, and responses will be used solely for research and educational purposes.
By proceeding with the survey, you consent to the collection and analysis of your responses. At the end of the survey, you may leave your email to be contacted for future input and acknowledged for your contributions. If you have any questions, please contact the research team.
Thank you for your valuable input!
The Task Force “Drug Hypersensitivity in Primary Immunodeficiencies” and the EAACI Immunodeficiencies working group